Curaleaf Holdings (CURLF) Change in Inventory (2019 - 2024)

Curaleaf Holdings (CURLF) posted quarterly Change in Inventory of -$415000.0 for Q4 2024, up 98.49% year-on-year from -$209074.8 in Q1 2024, and up 28.08% on a QoQ basis from -$577000.0 in Q3 2024.

Curaleaf Holdings (CURLF) Change in Inventory (2019 - 2024) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Change in Inventory for 6 consecutive years, with -$415000.0 the latest figure, recorded in Q4 2024.

  • Quarterly Change in Inventory rose 98.49% year-over-year to -$415000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$4.4 million (down 108.13% YoY) and the FY2025 annual result came in at $3.7 million, up 186.44% from the prior year.
  • Change in Inventory improved to -$415000.0 in Q4 2024 per CURLF's latest filing, from -$577000.0 in the prior quarter.
  • Over the last five years, Change in Inventory for CURLF reached as high as $56.7 million in Q4 2022 and fell as low as -$59.7 million in Q2 2021.
  • A 5-year average of -$10.9 million and a median of -$14.9 million in 2020 frame the typical range for Change in Inventory.
  • Annual changes were most pronounced in 2020 — Change in Inventory sank 1670.67% — and 2023, when it jumped 3802.58%.
  • Year by year, Change in Inventory stood at -$11.0 million in 2020, then surged by 537.23% to $48.3 million in 2021, then increased by 17.37% to $56.7 million in 2022, then slumped by 148.59% to -$27.5 million in 2023, then surged by 98.49% to -$415000.0 in 2024.
  • According to Business Quant data, Change in Inventory over the past three periods registered -$415000.0, -$577000.0, and -$27.5 million for Q4 2024, Q3 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -93.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 114.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 119.24 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 40.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 123.00 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -4.30 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -415,000.00
Dec 31, 2024 -415,000.00
Sep 30, 2024 -577,000.00
Sep 30, 2024 -577,000.00
Dec 31, 2023 -27.55 Mn
Dec 31, 2023 -27.55 Mn
Sep 30, 2023 24.16 Mn
Sep 30, 2023 24.16 Mn
Dec 31, 2022 56.70 Mn
Dec 31, 2022 56.70 Mn
Sep 30, 2022 619,000.00
Sep 30, 2022 619,000.00
Jun 30, 2022 -730,000.00
Jun 30, 2022 -730,000.00
Mar 31, 2022 -40.49 Mn
Mar 31, 2022 -40.49 Mn
Dec 31, 2021 48.31 Mn
Dec 31, 2021 48.31 Mn
Sep 30, 2021 -40.63 Mn
Sep 30, 2021 -40.63 Mn